SCHEMBL27810219

SCHEMBL27810219

C=CC(c1ccc(C(F)(F)F)cc1)S(=O)(=O)N1CCN(C(=O)c2cnc(N3CCC3)cc2C)C(C)C1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.37
▸ LMNA P02545 3/20 0.37
▸ HTT P42858 2/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ F13A1 P00488 1/20 0.36
▸ TGM2 P21980 1/20 0.36
▸ TGM1 P22735 1/20 0.36
▸ TACR1 P25103 2/20 0.36
▸ TACR3 P29371 2/20 0.36
▸ MEN1 O00255 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ PKM P14618 2/20 0.34
▸ EIF2AK4 Q9P2K8 2/20 0.34
▸ SMO Q99835 2/20 0.34
▸ L3MBTL1 Q9Y468 2/20 0.34
▸ GPBAR1 Q8TDU6 1/20 0.33
▸ TRPV1 Q8NER1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28791123 0.88 KDM4E (0.42) KDM4ESMN1; SMN2F13A1TGM2TGM1
Hydrochloric Acid SCHEMBL27810222 0.86 EIF2AK4 (0.36) KDM4ELMNAHTTSMN1; SMN2F13A1
SCHEMBL1430013 0.84 KDM4E (0.52) KDM4ELMNAHTTSMN1; SMN2F13A1
SCHEMBL27810218 0.80 KDM4E (0.37) KDM4ELMNAHTTSMN1; SMN2TACR1
SCHEMBL12965691 0.77 SMN1; SMN2 (0.44) KDM4ELMNAHTTSMN1; SMN2F13A1
Hydrochloric Acid SCHEMBL1429800 0.77 SMN1; SMN2 (0.44) KDM4ELMNAHTTSMN1; SMN2F13A1
SCHEMBL1429768 0.72 GAA (0.45) KDM4ELMNAHTTF13A1TGM2
SCHEMBL12965414 0.71 KDM4E (0.49) KDM4ELMNAF13A1TGM2TGM1
Hydrochloric Acid SCHEMBL1430123 0.71 KDM4E (0.59) KDM4ELMNASMN1; SMN2F13A1TGM2
Hydrochloric Acid SCHEMBL1430220 0.70 KDM4E (0.48) KDM4ELMNAF13A1TGM2TGM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102099337-B Piperazine derivatives useful as CAV2.2 calcium channel modulators CONVERGENCE PHARMACEUTICALS 2013-08-21 — — CN disclosed
CN-102099337-A Piperazine derivatives useful as CAV2.2 calcium channel modulators CONVERGENCE PHARMACEUTICALS 2011-06-15 — — CN disclosed
Send feedback